Search Results - "Colgan, J P"

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma by Witzig, T E, Reeder, C B, LaPlant, B R, Gupta, M, Johnston, P B, Micallef, I N, Porrata, L F, Ansell, S M, Colgan, J P, Jacobsen, E D, Ghobrial, I M, Habermann, T M

“…The phosphatidylinositol 3-kinase signal transduction pathway members are often activated in tumor samples from patients with non-Hodgkin's lymphoma (NHL)…”
Get full text

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma by Wilcox, R A, Ristow, K, Habermann, T M, Inwards, D J, Micallef, I N M, Johnston, P B, Colgan, J P, Nowakowski, G S, Ansell, S M, Witzig, T E, Markovic, S N, Porrata, L

“…Despite the use of modern immunochemotherapy regimens, almost 50% of patients with diffuse large-B-cell lymphoma will relapse. Current prognostic models,…”
Get full text

Bowel perforation in intestinal lymphoma: incidence and clinical features by Vaidya, R., Habermann, T.M., Donohue, J.H., Ristow, K.M., Maurer, M.J., Macon, W.R., Colgan, J.P., Inwards, D.J., Ansell, S.M., Porrata, L.F., Micallef, I.N., Johnston, P.B., Markovic, S.N., Thompson, C.A., Nowakowski, G.S., Witzig, T.E.

“…Perforation is a serious life-threatening complication of lymphomas involving the gastrointestinal (GI) tract. Although some perforations occur as the initial…”
Get full text

Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma by Porrata, L F, Rsitow, K, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Habermann, T M, Witzig, T E, Colgan, J P, Nowakowski, G S, Thompson, C A, Markovic, S N

“…A specific predictor during routine follow-up to ascertain risk for relapse after standard chemotherapy in non-Hodgkin's lymphoma (NHL) has not been…”
Get full text

Timing of Cenozoic Extension in the Southern Stillwater Range and Dixie Valley, Nevada by Colgan, J. P., Johnstone, S. A., Shuster, D. L.

“…The Dixie Valley fault bounds the east side of the Stillwater Range in west‐central Nevada and last ruptured in 1954. Offset basalts indicate that slip began…”
Get full text

Interpretation of Low‐Temperature Thermochronometer Ages From Tilted Normal Fault Blocks by Johnstone, S. A., Colgan, J. P.

“…Low‐temperature thermochronometry is widely used to measure the timing and rate of slip on normal faults. Rates are often derived from suites of footwall…”
Get full text

Electron-impact ionization of the Pb atom by Pindzola, M. S., Loch, S. D., Colgan, J. P.

“…Electron-impact ionization cross sections are calculated for the ground configuration of the Pb atom. Time-dependent close-coupling cross sections for the…”
Get full text

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma by PORRATA, Luis F, RISTOW, Kay, THOMPSON, Carrie, MARKOVIC, Svetomir N, COLGAN, Joseph P, HABERMANN, Thomas M, WITZIG, Thomas E, INWARDS, David J, ANSELL, Stephen M, MICALLEF, Ivana N, JOHNSTON, Patrick B, NOWAKOWSKI, Grzegorz S

“…Lymphopenia and tumor-associated macrophages are negative prognostic factors for survival in classical Hodgkin's lymphoma. We, therefore, studied whether the…”
Get full text

Testicular lymphoma is associated with a high incidence of extranodal recurrence by Fonseca, Rafael, Habermann, Thomas M., Colgan, Joseph P., O'Neill, Brian P., White, William L., Witzig, Thomas E., Egan, Kathleen S., Martenson, James A., Burgart, Lawrence J., Inwards, David J.

“…BACKGROUND Testicular lymphoma is a rare extranodal presentation of non‐Hodgkin lymphoma. The authors report long term follow‐up information regarding a group…”
Get full text

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma by Ansell, S M, Habermann, T M, Kurtin, P J, Witzig, T E, Chen, M G, Li, C Y, Inwards, D J, Colgan, J P

“…The International Prognostic Factor Index has been shown to predict the outcome of patients with predominantly B-cell lymphomas classified using traditional…”
Get more information

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas by Briski, R, Feldman, A L, Bailey, N G, Lim, M S, Ristow, K, Habermann, T M, Macon, W R, Inwards, D J, Colgan, J P, Nowakowski, G S, Kaminski, M S, Witzig, T E, Ansell, S M, Wilcox, R A

“…Peripheral T-cell lymphomas (PTCLs) are a heterogenous group of aggressive non-Hodgkin’s lymphomas that are incurable in the majority of patients with current…”
Get full text

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? by O'Neill, B P, O'Fallon, J R, Earle, J D, Colgan, J P, Brown, L D, Krigel, R L

“…Results of multiple radiation, chemotherapy, and combined treatment trials have shown that the fate of primary central nervous system lymphoma (PCNSL) patients…”
Get more information

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance) by Witzig, T E, LaPlant, B, Habermann, T M, McPhail, E, Inwards, D J, Micallef, I N, Colgan, J P, Nowakowski, G S, Ansell, S M, Johnston, P B

Get full text

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma by Porrata, L F, Ristow, K M, Habermann, T M, Macon, W R, Witzig, T E, Colgan, J P, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Nowakowski, G, Thompson, C A, Markovic, S N

“…The peripheral blood absolute lymphocyte/monocyte count ratio at diagnosis (ALC/AMC-DX) predicts survival in classical Hodgkin lymphoma (cHL). However, a…”
Get full text

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study by O'Connell, M J, Colgan, J P, Oken, M M, Ritts, Jr, R E, Kay, N E, Itri, L M

“…Twenty patients with disseminated favorable histology non-Hodgkin's lymphomas (16 patients) or chronic lymphocytic leukemia (four patients) who had not…”
Get more information

Computational atomic physics for plasma edge modeling by Schultz, D. R., Krstic, P. S., Minami, T., Pindzola, M. S., Robicheaux, F. J., Colgan, J. P., Loch, S. D., Griffin, D. C., Ballance, C. P., Badnell, N. R., Summers, H. P.

“…Atomic processes play important roles in the physics of the edge plasma and in enabling diagnostics. In this paper we illustrate a number of recent projects…”
Get full text

Acute porphyrias: diagnosis and management by Tefferi, A, Colgan, J P, Solberg, Jr, L A

“…To summarize recent information about acute porphyrias and to provide clinicians with a practical diagnostic and management approach, we reviewed the pertinent…”
Get more information

Patterns of failure in primary testicular non-Hodgkin's lymphoma by Martenson, Jr, J A, Buskirk, S J, Ilstrup, D M, Banks, P M, Evans, R G, Colgan, J P, Earle, J D

“…Patterns of failure were analyzed in 30 patients with testicular non-Hodgkin's lymphoma: 16 had stage IE disease, ten had stage IIE, and four had stage IV…”
Get more information

Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method by Witzig, T E, Banks, P M, Stenson, M J, Griepp, P R, Katzmann, J A, Habermann, T M, Colgan, J P, Gonchoroff, N J

“…The authors compared immunotyping (IT) results obtained by both standard frozen section (FS) and flow cytometry (FC) methods on 218 biopsies suggestive of…”
Get more information

Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease by Tefferi, A, Zellers, R A, Banks, P M, Therneau, T M, Colgan, J P

“…Histologic and paraffin immunohistologic studies were carried out on 32 patients with lymphocyte-predominance Hodgkin's disease (LPHD) seen from 1970 through…”
Get more information